The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
Open accessAbstract
Human PON1 is a HDL-associated lipolactonase capable of preventing LDL and cell membrane oxidation and is therefore considered to be atheroprotective. PON1 contributes to the antioxidative function of HDL and reductions in HDL-PON1 activity, prevalent in a wide variety of diseases with an inflammatory component, is believed to lead to dysfunctional HDL which can promote inflammation and atherosclerosis. However, PON1 is multifunctional and may contribute to other HDL functions such as in innate immunity, preventing infection by quorum sensing gram negative bacteria by destroying acyl lactone mediators of quorum sensing, and putative new roles in cancer development and the promotion of healthy ageing. In this review we explore the physiological roles of PON1 in disease development, as well as PON1 gene and protein structure, promiscuous activities and the roles of SNPs and ethnicity in determining PON1 activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Self-citationMACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
Self-citationNavab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 715
The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & Du, B. N. L. (1996) · Genomics · doi:10.1006/geno.1996.0225 · Cited by 673
Harel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646
Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42946 · Cited by 535
Bhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 533
Pharmacogenetics of paraoxonases: a brief review
Draganov, D. I., & Du, B. N. L. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0833-1 · Cited by 489
Modulation of paraoxonase (PON1) activity
Costa, L. G., Vitalone, A., Cole, T. B., & Furlong, C. E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.027 · Cited by 488
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Bouman, H. J., Schömig, E., van Werkum, J. W., Velder, J., Hackeng, C. M., Hirschhäuser, C., Waldmann, C., Schmalz, H.-G., ten Berg, J. M., & Taubert, D. (2011) · Nature Medicine · doi:10.1038/nm.2281 · Cited by 465
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
Structure−Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase
Khersonsky, O., & Tawfik, D. S. (2005) · Biochemistry · doi:10.1021/bi047440d · Cited by 456
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C., Castellani, L. W., Lusis, A. J., & Shih, D. M. (2002) · Circulation · doi:10.1161/01.cir.0000023623.87083.4f · Cited by 455
Aldridge, W. N. (1953) · Biochemical Journal · doi:10.1042/bj0530117 · Cited by 446
Atherosclerosis and Coronary Artery Disease
(1996) · Nature Medicine · doi:10.1038/nm0796-822 · Cited by 442
Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094247 · Cited by 435
Self-citationAviram, M., & Rosenblat, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.030 · Cited by 434
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study
Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M., & Mackness, M. (2003) · Circulation · doi:10.1161/01.cir.0000070954.00271.13 · Cited by 421
Self-citationHDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Self-citationDavidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
Jakubowski, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3957 · Cited by 398
Prenatal Exposure to Organophosphates, Paraoxonase 1, and Cognitive Development in Childhood
Engel, S. M., Wetmur, J., Chen, J., Zhu, C., Barr, D. B., Canfield, R. L., & Wolff, M. S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003183 · Cited by 396
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 393
Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 377
Self-citationJAKUBOWSKI, H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2277 · Cited by 370
Mackness, B., Durrington, P. N., & Mackness, M. I. (1998) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(98)00028-7 · Cited by 350
Self-citationIn utero pesticide exposure, maternal paraoxonase activity, and head circumference.
Berkowitz, G. S., Wetmur, J. G., Birman-Deych, E., Obel, J., Lapinski, R. H., Godbold, J. H., Holzman, I. R., & Wolff, M. S. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6414 · Cited by 340
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R., & Danesh, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15642-0 · Cited by 317
Jarvik, G. P., Rozek, L. S., Brophy, V. H., Hatsukami, T. S., Richter, R. J., Schellenberg, G. D., & Furlong, C. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2441 · Cited by 309
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Leviev, I., & James, R. W. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.516 · Cited by 308
Mackness, M. I., Abbott, C., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 305
Self-citationMazur, A. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43068-2 · Cited by 288
Li, W.-F., Costa, L. G., Richter, R. J., Hagen, T., Shih, D. M., Tward, A., Lusis, A. J., & Furlong, C. E. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00002 · Cited by 276
DEAKIN, S. P., & JAMES, R. W. (2004) · Clinical Science · doi:10.1042/cs20040187 · Cited by 267
The three-gene paraoxonase family: Physiologic roles, actions and regulation
Précourt, L.-P., Amre, D., Denis, M.-C., Lavoie, J.-C., Delvin, E., Seidman, E., & Levy, E. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.076 · Cited by 264
Costa, L. G., Cole, T. B., Jarvik, G. P., & Furlong, C. E. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152421 · Cited by 264
Homocysteine Thiolactone: Metabolic Origin and Protein Homocysteinylation in Humans
Jakubowski, H. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.377s · Cited by 255
Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107440200 · Cited by 251
Mechanisms of Disease: proatherogenic HDL—an evolving field
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., & Fogelman, A. M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0245 · Cited by 249
Rosenblat, M., Gaidukov, L., Khersonsky, O., Vaya, J., Oren, R., Tawfik, D. S., & Aviram, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512595200 · Cited by 242
Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing
Ozer, E. A., Pezzulo, A., Shih, D. M., Chun, C., Furlong, C., Lusis, A. J., Greenberg, E. P., & Zabner, J. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.023 · Cited by 226
Mackness, B., Hunt, R., Durrington, P. N., & Mackness, M. I. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1233 · Cited by 210
Self-citationHaley, R. W., Billecke, S., & La Du, B. N. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8703 · Cited by 204
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues
Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltrán, R., Joven, J., & Camps, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.023 · Cited by 196
Self-citationCosta, L. G., Giordano, G., & Furlong, C. E. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 189
Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome
Mackness, B., Quarck, R., Verreth, W., Mackness, M., & Holvoet, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000222924.62641.aa · Cited by 184
Self-citationThe Histidine 115-Histidine 134 Dyad Mediates the Lactonase Activity of Mammalian Serum Paraoxonases
Khersonsky, O., & Tawfik, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512594200 · Cited by 180
Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity
Costa, L. G., Giordano, G., Cole, T. B., Marsillach, J., & Furlong, C. E. (2013) · Toxicology · doi:10.1016/j.tox.2012.07.011 · Cited by 179
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells
Mackness, B., Hine, D., Liu, Y., Mastorikou, M., & Mackness, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.056 · Cited by 178
Self-citationTang, W. H. W., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F. R., Erdmann, J., Kathiresan, S., The CARDIoGRAM Consortium, Roberts, R., McPherson, R., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.253930 · Cited by 174
Paraoxonase 1, Agricultural Organophosphate Exposure, and Parkinson Disease
Manthripragada, A. D., Costello, S., Cockburn, M. G., Bronstein, J. M., & Ritz, B. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c15ec6 · Cited by 170
Study of factors influencing the decreased HDL associated PON1 activity with aging
Seres, I., Paragh, G., Deschene, E., Fulop, T., & Khalil, A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.08.001 · Cited by 169
Ross, S. M., Brewin, C. R., Curran, H. V., Furlong, C. E., Abraham-Smith, K., & Harrison, V. (2010) · Open Research Online - ORO (The Open University) · Cited by 164
Teiber, J. F., Horke, S., Haines, D. C., Chowdhary, P. K., Xiao, J., Kramer, G. L., Haley, R. W., & Draganov, D. I. (2008) · Infection and Immunity · doi:10.1128/iai.01606-07 · Cited by 159
Pharmacogenetics of Drug Metabolism
Flockhart, D. A., & Desta, Z. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373639-0.00021-2 · Cited by 151
The paraoxonase 1, 2 and 3 in humans
Rajković, M. G., Rumora, L., & Barišić, K. (2011) · Biochemia Medica · doi:10.11613/bm.2011.020 · Cited by 150
Paraoxonase: A multifaceted biomolecule
Goswami, B., Tayal, D., Gupta, N., & Mallika, V. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.025 · Cited by 148
Rozenberg, O., Shih, D. M., & Aviram, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.030 · Cited by 147
Ahmed, Z., Ravandi, A., Maguire, G. F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010459200 · Cited by 145
Jaouad, L., de Guise, C., Berrougui, H., Cloutier, M., Isabelle, M., Fülöp, T., Payette, H., & Khalil, A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.012 · Cited by 138
Eskenazi, B., Huen, K., Marks, A., Harley, K. G., Bradman, A., Barr, D. B., & Holland, N. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002234 · Cited by 133
da Silva, J., de Moraes, C. R. C., Heuser, V. D., Andrade, V. M., da Silva, F. R., Kvitko, K., Emmel, V. E., Rohr, P., Bordin, D. L., Andreazza, A. C., et al. (2008) · Mutagenesis · doi:10.1093/mutage/gen031 · Cited by 129
Hyperlipidaemia: Diagnosis and Management
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-1-99_2 · Cited by 128
Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates
Richter, R. J., Jarvik, G. P., & Furlong, C. E. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.811638 · Cited by 127
Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
Aharoni, S., Aviram, M., & Fuhrman, B. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.005 · Cited by 125
Rodrigo, L. S., Hernández, A. F., López-Caballero, J. J., Gil, F., & Pla, A. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00225-3 · Cited by 125
Dansette, P. M., Rosi, J., Bertho, G., & Mansuy, D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx2004085 · Cited by 120
Expression of human paraoxonase (PON1) during development
Cole, T. B., Jampsa, R. L., Walter, B. J., Arndt, T. L., Richter, R. J., Shih, D. M., Tward, A. D., Lusis, A. J., Jack, R. M., Costa, L. G., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200306000-00007 · Cited by 110
Deakin, S., Bioletto, S., Bochaton‐Piallat, M., & James, R. W. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.002 · Cited by 105
Harley, K. G., Huen, K., Schall, R. A., Holland, N., Bradman, A., Barr, D. B., & Eskenazi, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023923 · Cited by 103
Koren-Gluzer, M., Aviram, M., Meilin, E., & Hayek, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.119 · Cited by 101
Paraoxonase gene polymorphisms and sporadic ALS
Słowik, A., Tomik, B., Wołkow, P. P., Partyka, D., Turaj, W., Malecki, M. T., Pera, J., Dziedzic, T., Szczudlik, A., & Figlewicz, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000219565.32247.11 · Cited by 93
Camps, J., Pujol, I., Ballester, F., Joven, J., & Simó, J. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01502-10 · Cited by 88
Stoltz, D. A., Ozer, E. A., Taft, P. J., Barry, M., Liu, L., Kiss, P. J., Moninger, T. O., Parsek, M. R., & Zabner, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35147 · Cited by 88
Wang, M., Lang, X., Zou, L.-J., Huang, S., & Xu, Z. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.028 · Cited by 85
Liu, M., Scalia, R. G., Mehta, J. L., & Williams, K. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.255471 · Cited by 81
Paraoxonase gene mutations in amyotrophic lateral sclerosis
Ticozzi, N., LeClerc, A. L., Keagle, P. J., Glass, J. D., Wills, A.-M. A., van Blitterswijk, M., Bosco, D. A., Rodríguez‐Leyva, I., Gellera, C., Ratti, A., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21993 · Cited by 80
PON1 is a longevity gene: Results of a meta-analysis
Lescai, F., Marchegiani, F., & Franceschi, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.001 · Cited by 76
Lee, B. W., London, L., Paulauskis, J. D., Myers, J. E., & Christiani, D. C. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000052953.59271.e1 · Cited by 75
Liu, M., Liao, Y., Lin, R., Wang, Y., Hsi, E., Lin, H., Chen, K., & Juo, S. H. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.036 · Cited by 75
Berrougui, H., Loued, S., & Khalil, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.019 · Cited by 71
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
Rozenberg, O., Shiner, M., Aviram, M., & Hayek, T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.02.012 · Cited by 71
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation
Hine, D. G., Mackness, B., & Mackness, M. (2011) · IUBMB Life · doi:10.1002/iub.588 · Cited by 64
Self-citationStructural Organization of the HumanPON1Gene
Clendenning, J. B., Humbert, R., Green, E. D., Wood, C. M., Traver, D. J., & Furlong, C. E. (1996) · Genomics · doi:10.1006/geno.1996.0401 · Cited by 63
Birjmohun, R. S., Vergeer, M., Stroes, E. S. G., Sandhu, M. S., Ricketts, S. L., Tanck, M. W. T., Wareham, N. J., Jukema, J. W., Kastelein, J. J. P., Khaw, K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006809 · Cited by 63
Reddy, S. T., Devarajan, A., Bourquard, N., et al. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328304b64e · Cited by 62
Guns, P., Assche, T. V., Verreth, W., Fransen, P. F., Mackness, B., Mackness, M., Holvoet, P., & Bult, H. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707585 · Cited by 59
Self-citationThe Hunt for Nutritional and Pharmacological Modulators of Paraoxonase
Durrington, P. N., Mackness, B., & Mackness, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000027414.34728.1f · Cited by 58
Self-citationDeterminants of Paraoxonase 1 Status: Genes, Drugs and Nutrition
Schrader, C., & Rimbach, G. H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798347216 · Cited by 57
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Wang, M., Lang, X., Cui, S., Zou, L.-J., Cao, J., Wang, S., & Wu, X.-T. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1478 · Cited by 56
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques
Marsillach, J., Camps, J., Beltrán‐Debón, R., Rull, A., Aragonès, G., Maestre‐Martínez, C., Sabench, F., Hernández, M., Castillo, D. D., Joven, J., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02411.x · Cited by 55
Self-citationRodríguez-Sanabria, F., Rull, A., Beltrán‐Debón, R., Aragonès, G., Camps, J., Mackness, B., Mackness, M., & Joven, J. (2010) · Journal of Molecular Histology · doi:10.1007/s10735-010-9299-x · Cited by 54
Self-citationLow human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes
Ikeda, Y., Inoue, M., Suehiro, T., et al. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0066-3 · Cited by 52
Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation
Rosenblat, M., Volkova, N., Ward, J., & Aviram, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.054 · Cited by 47
Interaction between organophosphate pesticide exposure and PON1 activity on thyroid function
Lacasaña, M., López‐Flores, I., Rodríguez‐Barranco, M., Aguilar-Garduño, C., Muñoz, J. B., Pérez-Méndez, O. A., Gamboa, R., González-Alzaga, B., Bassol, S., & Cebrián, M. E. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.024 · Cited by 43
High-density lipoprotein impedes glycation of low-density lipoprotein
Younis, N. N., Soran, H., Charlton-Menys, V., Sharma, R., Hama, S., Pemberton, P. W., Elseweidy, M. M., & Durrington, P. N. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112454309 · Cited by 38
Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Camps, J., Marsillach, J., & Joven, J. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788681591 · Cited by 38
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study
Troughton, J. A., Woodside, J. V., YARNELL, J. W. G., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.019 · Cited by 37
Dowling, P., Hayes, C. A., Ting, K. R., Hameed, A., Meiller, J., Mitsiades, C. S., Anderson, K. C., CLYNES, M. M., Clarke, C., Richardson, P. G. G., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-904 · Cited by 36
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS
Wills, A.-M. A., Landers, J. E., Zhang, H., Richter, R. J., Caraganis, A., Cudkowicz, M., Furlong, C. E., & Brown, R. H. (2008) · Neurology · doi:10.1212/01.wnl.0000305956.37931.dd · Cited by 35
García‐Heredia, A., Marsillach, J., Rull, A., Triguero, I., Fort-Gallifa, I., Mackness, B., Mackness, M., Shih, D. M., Joven, J., & Camps, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/156053 · Cited by 35
Self-citationAdditional Common Polymorphisms in thePONGene Cluster Predict PON1 Activity but Not Vascular Disease
Kim, D. S., Burt, A., Ranchalis, J., Richter, R. J., Marshall, J. K., Eintracht, J. F., Rosenthal, E. A., Furlong, C. E., & Jarvik, G. P. (2012) · Journal of Lipids · doi:10.1155/2012/476316 · Cited by 34
No or only population-specific effect of PON1 on human longevity: A comprehensive meta-analysis
Caliebe, A., Kleindorp, R., Blanché, H., Christiansen, L., Puca, A. A., Rea, I. M., Slagboom, P. E., Flachsbart, F., Christensen, K., Rimbach, G. H., et al. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.03.003 · Cited by 29
da Silva, J. L., Vinagre, C. G. C., Morikawa, A. T., Alves, M. J. N. N., Mesquita, C. H., & Maranhão, R. C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.014 · Cited by 29
Lack of association of PON polymorphisms with sporadic ALS in an Italian population
Ricci, C., Battistini, S., Cozzi, L., Benigni, M., Origone, P., Verriello, L., Lunetta, C., Cereda, C., Milani, P., Greco, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.010 · Cited by 22
Regulation of FMO and PON Detoxication Systems in ALS Human Tissues
Gagliardi, S., Abel, K. J., Bianchi, M., Milani, P., Bernuzzi, S., Corato, M. D., Ceroni, M., Cashman, J. R., & Cereda, C. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9356-1 · Cited by 19
Pezzulo, A. A., Hornick, E. E., Rector, M. V., Estin, M. L., Reisetter, A. C., Taft, P. J., Butcher, S., Carter, A. B., Manak, J. R., Stoltz, D. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043777 · Cited by 17
Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL
Shah, P. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32833f0382 · Cited by 16
Dynamic variation in allele-specific gene expression of Paraoxonase-1 in murine and human tissues
Parker-Katiraee, L., Bousiaki, E., Monk, D., Moore, G. E., Nakabayashi, K., & Scherer, S. W. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn222 · Cited by 14
Mackness, B., Marsillach, J., Elkeles, R. S., Godsland, I. F., Feher, M. D., Rubens, M. B., Flather, M. D., Humphries, S. E., Cooper, J. A., & Mackness, M. (2012) · Disease Markers · doi:10.1155/2012/953768 · Cited by 14
Self-citationCurrent Aspects of Paraoxonase-1 Research
Mackness, M., & Mackness, B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-407867-3.00011-1 · Cited by 12
Self-citationBlood α-synuclein in agricultural pesticide handlers in central Washington State
Nielsen, S. S., Checkoway, H., Zhang, J., Hofmann, J. N., Keifer, M., Paulsen, M., Farin, F. M., Cook, T. J., & Simpson, C. D. (2014) · Environmental Research · doi:10.1016/j.envres.2014.10.014 · Cited by 9
Lee, Y. S., Park, C. O., Noh, J. Y., Jin, S., Lee, N. R., Noh, S., Lee, J. H., & Lee, K. H. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01555.x · Cited by 9
Cited by
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T., & Catapano, A. L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac605 · Cited by 401
Homocysteine Modification in Protein Structure/Function and Human Disease
Jakubowski, H. (2019) · Physiological Reviews · doi:10.1152/physrev.00003.2018 · Cited by 307
Effects of curcumin on HDL functionality
Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.008 · Cited by 186
Nazir, S., Jankowski, V., Bender, G., Zewinger, S., Rye, K.-A., & van der Vorst, E. P. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.006 · Cited by 140
Metadata
- Authors
- Mackness, M., & Mackness, B.
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 567
- Issue
- 1
- Pages
- 12-21
- ISSN
- 0378-1119 (ISSN-L)
- OpenAlex
- W1869060308
- Cited by
- 310
- References
- 121
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.